" class="no-js "lang="en-US"> Anona Bamford, PerkinElmer, on Single-Cell RNA Sequencing
Tuesday, April 23, 2024

Anona Bamford Ph.D., PerkinElmer Applied Genomics, on Single-Cell RNA Sequencing

In this interview with Anona Bamford from PerkinElmer at the 33rd ECCMID 2023 event, she discusses a range of products and PerkinElmer acquisitions that are helping scientists and healthcare professionals achieve a healthier world.

Bamford highlights the role of new technologies, such as next-generation RNA sequencing. She explains how these technologies can provide more precise and comprehensive information, which can help with the development of targeted treatments, as well as helping keep costs down.

Anona Bamford finishes the interview by sharing new products that are expected to be launched by the end of the year.

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more